pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)
Unknown · small molecule · CD30+ Peripheral T-cell Lymphoma
Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide) for CD30+ Peripheral T-cell Lymphoma is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code 2024470
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- CD30+ Peripheral T-cell Lymphoma
- Status
- active
- Trials
- 1